Your Cart
Your cart is empty

Looks like you haven't added any test / checkup to your cart

Add Test / Checkup
User Sign In Health checkup offers

IHC - Lymphoma Review Diagnostic and Prognostication Test, Price, Normal Range | Sprint Diagnostics Hyderabad

  • Home
  • Hyderabad
  • Lab Test
  • IHC - Lymphoma Review Diagnostic and Prognostication - Suspect Large Cell Lymphoma (10-12 Markers)

Immunohistochemistry (IHC) plays a significant role in diagnosing and classifying lymphomas, particularly large cell lymphomas. Lymphomas are a group of cancers that begin in the lymphocytes, which are white blood cells and an essential part of the immune system. Large cell lymphomas are so named because the lymphocytes appear larger than normal when viewed under a microscope.

In the Lymphoma Review Diagnostic and Prognostication - Suspect Large Cell Lymphoma test, 10 to 12 markers are used. This panel of markers helps to determine the type of lymphoma, its growth rate, and potential response to treatment, all of which contribute to the disease's prognostication or predicted course and outcome.

  • Test Name: IHC - Lymphoma Review Diagnostic and Prognostication - Suspect Large Cell Lymphoma (10-12 Markers)
  • Sample Type: Tissue
  • Preparations Required: No specific preparation is required for this test.
  • Report Time: 4 days

Home Sample Collection Process

Book your convenient slot
Book your convenient slot
Sample Collection by Phlebotomist
Sample Collection by Phlebotomist
Reporting of the sample at lab
Reporting of the sample at lab
Download Reports
Download Reports
Frequently Asked Questions

This test uses various markers (usually antibodies) to identify specific proteins on the surface of cells. By identifying these proteins, doctors can determine the type of cells present in a tissue sample, which helps to diagnose and classify lymphoma..

This test is crucial because large cell lymphomas can present differently and may require different treatment approaches. Accurately classifying the lymphoma type helps guide treatment decisions and provides prognostic information.

No fasting is required for this test.

The test is performed on a tissue sample, typically obtained through a biopsy. The tissue sample is then sent to the laboratory where it is prepared for analysis.

This test is typically performed once when diagnosing a lymphoma. However, if your doctor needs to monitor the progress of your disease or response to treatment, they may recommend additional testing.

The normal range will vary depending on the specific markers used in the test. Your doctor will interpret your results based on these ranges, the combination of markers, and other diagnostic information.

Certain medications, infections, or other medical conditions may impact the results of this test. Always share your complete medical history with your doctor.

If your test results are abnormal, you should consult a hematologist or oncologist.

The main risk associated with this test is related to the biopsy procedure, which may cause bleeding, infection, or injury to surrounding tissues. However, these risks are minimal and the procedure is generally safe.

There is no specific preparation required for the test. However, it's important to inform your doctor about any medications you're taking as some medications may affect the test results.

No, this test requires a tissue sample which must be collected in a medical facility by a healthcare professional.

Abnormal results may indicate the presence of large cell lymphoma. The specific abnormalities detected can help classify the type of lymphoma, predict its course, and guide treatment decisions.

Your doctor may also order other tests, such as complete blood count (CBC), computerized tomography (CT) scans , or bone marrow biopsy, to confirm the diagnosis and evaluate the extent of the disease.

Yes, the panel of markers used in this test can help differentiate between different types of large cell lymphoma.

Prognostication refers to the prediction of the likely course and outcome of the disease. The markers used in this test can provide important prognostic information.

The tissue sample for this test is usually collected through a biopsy. This procedure involves removing a small piece of tissue from the body, which is then sent to a laboratory for examination. The process is usually performed under local anesthesia and may involve a minor surgical procedure depending on the biopsy site.

While this test does not directly determine the stage of the lymphoma, it provides valuable information on the type and behavior of the lymphoma cells. Other diagnostic tests and procedures, such as imaging studies and further biopsy examinations, are typically required to establish the stage of the disease.

Yes, the markers identified in the Lymphoma Review Diagnostic and Prognostication - Suspect Large Cell Lymphoma test can provide insights into how the lymphoma might respond to different treatments. This information is invaluable in formulating an effective treatment plan.

If a specific marker is positive, it means the corresponding protein was found on the surface of the cells in the tissue sample. This can provide important information about the type of lymphoma and can help guide treatment decisions.

This test can help detect and classify various types of large cell lymphomas, including Diffuse Large B-Cell Lymphoma (DLBCL), Anaplastic Large Cell Lymphoma (ALCL), and Follicular Lymphoma grade 3, among others.

The Lymphoma Review Diagnostic and Prognostication - Suspect Large Cell Lymphoma test is highly reliable when performed by experienced pathologists in a qualified laboratory. However, results may sometimes be challenging to interpret and may need to be correlated with other clinical and diagnostic findings.

The pain associated with this test is primarily due to the biopsy procedure, which can cause mild discomfort. However, local anesthesia is typically used to minimize pain.

While this test primarily aids in diagnosis and prognostication, it may be repeated if your doctor needs to reassess the type or behavior of the lymphoma during treatment.

After the test, your doctor will review the results in conjunction with your symptoms and other test results to make a diagnosis. If a large cell lymphoma is confirmed, further tests may be needed to determine the stage and plan treatment.

Generally, lifestyle factors do not affect the results of this test. However, it's always important to maintain a healthy lifestyle to support your overall health and well-being, especially when dealing with a serious condition like lymphoma.

Accurate diagnosis and classification of lymphoma are crucial for its management. With the help of tests like the Lymphoma Review Diagnostic and Prognostication - Suspect Large Cell Lymphoma, doctors can develop personalized treatment plans that offer the best chances of success. As a patient, understanding these diagnostic processes can help you stay informed and make better health decisions.

Schedule Test in Your Available Time
Locations Near You in Hyderabad
  • 4KM from Madhapur
  • 3KM from Banjara Hills
  • 1.9KM from Yusufguda
  • 3KM from Madhura Nagar
  • 5KM from Shaikpet